MedTrace Logo

Short- and Long-Term Effects of Whole-Body Photobiomodulation in Type II Diabetes Patients: A Protocol for a Controlled Clinical Trial

NCT07047248 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2025-07-02

No results posted yet for this study

Summary

The development of an integral and global treatment to improve the quality of life in those withType II Diabetes Patients is challenging, thus a whole body Photobiomodulation (PBM) therapy program is proposed as an effective option.

Conditions

  • Type II Diabetes Mellitus

Interventions

DEVICE

PBM

A whole body red light therapy (NovoTHOR®) will be carried out during 20 minutes

OTHER

Placebo PBM

A placebo whole body red light will be carried out during 20 minutes

Sponsors & Collaborators

  • clinical professor

    collaborator UNKNOWN

  • University of Malaga

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-30
Primary Completion
2025-09-30
Completion
2026-01-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07047248 on ClinicalTrials.gov